EU regulator supports a label expansion of Novo Nordisk’s diabetes drug to reflect its potential to lower the risk of ...

A dOZEN YEARS ago Spain was a byword for economic failure. The country’s government and banks appeared to be locked in a ...

Who shone in 2024? Check out the countries that overcame global challenges and reached the top of the financial podium ...

Cora Olsen, Director of Sustainability Cora brings a wealth of more than 20 years of expertise stemming from her noteworthy career in sustainability including Sustainability Advisor at EY, Global Lead ...

Market multiples for Novo Nordisk are also attractive now, especially with a forward P/E for 2025 at 28.3x. Learn more about NVO stock here.

In a report released today, Peter Welford from Jefferies maintained a Sell rating on Novo Nordisk (0QIU – Research Report). The company’s ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo Nordisk's Lotte Bjerre Knudsen says her determination is a key part of the success, but she also stays humble.

In a report released today, Jo Walton from UBS maintained a Hold rating on Novo Nordisk (0QIU – Research Report), with a price target of ...

Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holding ...

Denmarks economic prospects are surging, with the government revising GDP growth forecasts upwards for 2024 and 2025, largely ...

In recent months Novo Nordisk has invested several billions of dollars to boost its manufacturing capacity—including its ...